The New Zealand Ministry of Health released a long-anticipated report this week, stating that there is limited evidence supporting the use of puberty-blocking drugs for children suffering from gender identity issues.The ministry called for a more cautious approach to their prescription, aligning with a growing global trend towards tightening regulations on what critics had for years argued were experimental practices. The ministry stated in a release there is "a lack of good quality evidence to back the effectiveness and safety of puberty blockers when used for this purpose." The government agency also announced a public consultation process, inviting submissions until...